Modulation of B cell activation by extracellular vesicles and potential alteration of this pathway in patients with rheumatoid arthritis
Authors:
Open Access
- 16 July 2022
- journal article
- research article
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 24 (1) , 1-19
Abstract
Background: Extracellular vesicles are involved in the intercellular communication of the immune system. In rheumatoid arthritis (RA), these structures are considered a source of autoantigens that drive proinflammatory responses of innate immune cells. A high concentration of circulating medium/large size extracellular vesicles (m/lEVs) and m/lEVs forming immune complexes (m/lEV-ICs) have been associated with disease activity and systemic inflammation in patients with RA. B cells are central components of RA immunopathology because of their involvement in the production of autoantibodies, antigen presentation, and cytokine production. However, the effect of m/lEVs on B cell function in the context of RA and other autoimmune diseases remains unknown. Methods: We evaluated the effect of m/lEVs obtained from healthy donors (HD) and patients with RA on B cell responses in vitro. In addition, we evaluated the effect of pre-exposition of monocyte-derived macrophages (MDM) to m/lEVs on activation of autologous B cells from HD and patients. Results: The presence of m/lEVs reduced the frequency of CD69+ and CD86+ B cells from HD activated by an agonist of antigen receptor. This regulation of the B cell activation markers by m/lEVs was partially dependent on phosphatidylserine binging. These m/lEVs also reduced the proliferation, calcium mobilization, and global phosphorylation of tyrosine. Similar responses were observed in B cells from patients with RA. However, the presence of m/lEVs promoted high antibody levels in B cells cultured with T cell-dependent stimuli by 7 days. In addition, despite the direct inhibitory effect of m/lEVs on early B cell responses, when B cells were cocultured with autologous MDM previously exposed to m/lEVs or m/lEV-ICs, an increased frequency of CD69+ B cells from patients with RA was observed, albeit not with cells from HD. Conclusions: These data together suggest that m/lEVs have a direct modulatory effect in early responses of B cells through B cell receptor that can potentially fail in patients with RA because of the impact of these vesicles over cells of the innate immune system. This phenomenon can potentially contribute to the loss of tolerance and disease activity in patients with RA.Keywords
Funding Information
- Colciencias (727-2015)
- Universidad de Antioquia (2015-7668)
This publication has 67 references indexed in Scilit:
- The exposure of autoantigens by microparticles underlies the formation of potent inflammatory components: the microparticle‐associated immune complexesEMBO Molecular Medicine, 2012
- Regulatory B cells are identified by expression of TIM-1 and can be induced through TIM-1 ligation to promote tolerance in miceJournal of Clinical Investigation, 2011
- A filtration-based protocol to isolate human Plasma Membrane-derived Vesicles and exosomes from blood plasmaJournal of Immunological Methods, 2011
- Circulating microparticles remain associated with complement activation despite intensive anti-inflammatory therapy in early rheumatoid arthritisAnnals of the Rheumatic Diseases, 2010
- Platelets Amplify Inflammation in Arthritis via Collagen-Dependent Microparticle ProductionScience, 2010
- Increased levels of circulating microparticles in primary Sjögren's syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activityArthritis Research & Therapy, 2009
- Microparticle-induced release of B-lymphocyte regulators by rheumatoid synoviocytesArthritis Research & Therapy, 2009
- Conduits Mediate Transport of Low-Molecular-Weight Antigen to Lymph Node FolliclesImmunity, 2009
- Recent developments in the immunobiology of rheumatoid arthritisArthritis Research & Therapy, 2008
- Subcapsular sinus macrophages in lymph nodes clear lymph-borne viruses and present them to antiviral B cellsNature, 2007